TripAdvisor veteran Christine Petersen joins Treato to drive aggressive growth plan
PRINCETON, New Jersey, January 27, 2015 /PRNewswire/ --
"The addition of Christine Petersen as Chief Consumer Officer and CMO brings Treato the marketing leadership needed to drive our aggressive growth plan," said Ido Hadari, Treato CEO. "She has the experience and knowledge in the online consumer market as well as marketing and product development expertise to elevate Treato.com as the premier health research site. We look forward to her extensive 'know-how' insights in expanding Treato's market presence and in enhancing our product offerings."
In her new role as Chief Consumer Officer and CMO, Ms. Petersen will lead Treato's global marketing initiatives and oversee development and growth of the company's consumer health business.
Christine joins most recently from TripAdvisor where between 2004 and 2013 she served first as the company's first Chief Marketing Officer leading global growth and then as President of TripAdvisor for Business, establishing and growing the b2b arm. Christine has over 20 years of marketing and product experience with strong global digital experience and proven success in building brands and businesses from start-up to category winners. Earlier in her career, she held executive positions at American Express, Travelocity, Fidelity Investments and Charles Schwab & Co. Christine holds a BA in Economics from Colby College and an MBA from Columbia University with a concentration in marketing and international business. She also serves as an independent director for Bankrate, Inc. (NYSE: RATE).
About Treato
Treato is the only scale source for real-time "patient voice" intelligence, collected from billions of patient conversations from across the social web. Treato turns these social health experiences into meaningful insights through its free patient website Treato.com and professional Treato IQ platform designed specifically for the health and life sciences industries.
Treato is privately held and backed by leading funds including Reed Elsevier Ventures, OrbiMed Partners, New Leaf Venture Partners and Western Technology Investments.
Supporting Resources:
SOURCE Treato